Reflect Orbital, a new startup, plans to monetize solar energy by providing sunlight to solar farms 24 hours a day.
Reflect Orbital is planning to develop a constellation of satellites that will reflect sunlight to solar farms during nighttime hours, transforming the efficiency and reach of solar energy generation.
This approach addresses the key limitations of solar power: its dependence on daylight. By extending the availability of sunlight to solar farms, enabled by advancements in space technology, Reflect Orbital's technology can significantly increase the contribution of solar energy to the global energy mix.
Reflect Orbital is currently designing its first satellite, marking the next phase in its mission to harness space-based solar power.
This technology not only has the potential to transform the renewable energy sector but also raises questions about the future of energy infrastructure and the role of space in supporting sustainable development.
Efficient transmission of energy over long distances from space or high altitudes remains a challenge. Additionally, the environmental impact of beaming concentrated solar energy through the atmosphere needs careful consideration.
<script type="application/ld+json">
{
"@context": "https://schema.org",
"@type": "Article",
"mainEntityOfPage": {
"@type": "WebPage",
"@id": "https://www.themoney.game/stories/a-new-dawn-for-solar-energy"
},
"headline": "A New Dawn For Solar Energy",
"description": "Reflect Orbital, a new startup, plans to monetize solar energy by providing sunlight to solar farms 24 hours a day.",
"image": "",
"author": {
"@type": "Organization",
"name": "The Money Game",
"url": "https://www.themoney.game"
},
"publisher": {
"@type": "Organization",
"name": "",
"logo": {
"@type": "ImageObject",
"url": ""
}
},
"datePublished": "2024-03-13"
}
</script>
Actions
Pages
Subscribe for newsletter
Stories
Worldcoin, led by Sam Altman, is pioneering a new type of digital identification by integrating World ID with top platforms, offering a new approach to identity verification. The technology makes it easier to distinguish between bots and "verified humans" online, providing developers with a more streamlined way to build integrations.
Worldcoin combines blockchain technology with practical applications across platforms like Minecraft, Reddit, Telegram, Shopify, and Mercado Libre.
The company has faced criticism, including a ban in Kenya over concerns about data security and privacy measures. Critics have also alleged that Worldcoin targets developing countries, offering participants outside the U.S. and some other countries 25 WLD tokens (worth approximately $60.5) for signing up. However, Worldcoin remains focused on global expansion and improving its platform.
The deployment of Worldcoin's technology in developing countries highlights blockchain's potential to provide solutions in varied economic landscapes while also raising concerns about 'crypto-colonialism' and exploitation in less-regulated markets.
Story
The NFT trading volume experienced a significant increase of $99 million in October compared to the previous month, breaking a yearlong downward trend.
The resurgence in NFT trading volume coincides with Bitcoin's price bouncing above $35,000, reaching its highest in 16 months. Ethereum also experienced a 50% jump in NFT trading volume, maintaining its leadership position across all networks.
At its peak, the NFT market transacted over $40 billion on digital assets and artwork on Ethereum, followed by a significant crash in 2022, causing a 97% drop in the overall NFT market volume.
Story
The Multidisciplinary Association for Psychedelic Studies (MAPS) has submitted its application to the FDA for the approval of MDMA-assisted therapy for patients with PTSD.
This marks a significant moment in psychedelic research for therapeutic use following 30 years of clinical research. The anticipation of MDMA's regulatory approval reflects a growing understanding of its therapeutic benefits, challenging long-held stigmas associated with psychedelic drugs.
MAPS’ MDMA application could see FDA approval by August with priority review. The organization’s goal is to explore the therapeutic potential of MDMA in areas where effective treatments are currently limited, with a particular emphasis on disorders that disproportionately affect women.
Founded in 1986, MAPS initiated its first clinical trial involving MDMA for PTSD in 2004. The MAPS Public Benefit Organization, focused on FDA approval, was launched in 2014.
Story
Innovators
Scroll
Open
Close